A cute intracerebral hemorrhage (ICH) is the least treatable form of stroke affecting more than a million people in the world each year.
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The study was approved by the ethics committees for each site and informed consent was obtained from all patients or relevant surrogates. Brain imaging was performed according to standardized techniques. Digital computed tomographic images were collected in uncompressed DICOM format and analyzed centrally for the presence of bleeding into the subarachnoid space, location and volume of hematoma, and any intraventricular extension. Subarachnoid extension of ICH was classified into sulcal and generalized patterns, the latter was further classified according to the modified Fisher scale. 5 Outcomes were death or major disability, defined as a modified Rankin Scale (mRS) score 6 of 3 to 6, death, major disability (mRS, [3] [4] [5] , and an ordinal analysis of mRS scores at 7, 28, and 90 days.
Results
Overall, 2582 participants with information on baseline computed tomography and 90-day mRS were included in analyses. There were 192 (7%) patients with subarachnoid extension of ICH at baseline, who had significantly higher National Institute of Health Stroke Scale scores and larger hematoma volumes (all P<0.0001; Table I in the online-only Data Supplement).
The Table shows that subarachnoid extension was associated with increased risk of death or major disability at 90 days (71% versus 53%; P<0.0001). Likewise, patients with subarachnoid extension had higher risks of poorer function on ordinal analysis of mRS scores (P<0.0001; Figure) . The association between subarachnoid extension and death or major disability remained significant in multivariable-adjusted model 1 (P<0.0001; Table) . However, there was no longer any independent significance after further adjustment for baseline hematoma volume (model 2; P=0.62). Additional adjustment of seizures during follow-up did not change the findings (Table II in 
Discussion
In INTERACT2, which included >2500 patients, subarachnoid extension of ICH was associated with increased risks of death or major disability, but not after adjustment for baseline hematoma volume. These findings suggest that hematoma volume is the primary determinant of poor prognosis in patients with subarachnoid extension of ICH.
Our results differ from those of a previous hospital-based observational study of acute ICH, where a strong independent association was evident between subarachnoid extension and 14-day mortality and 28-day disability. 2 However, that study reported a much higher rate of subarachnoid extension (40%), possibly because of differences in hematoma location and use of antithrombotics and was based on relatively small numbers (234) of patients. The greater sample size in INTERACT2 allowed us to undertake more precise adjustment for prognostic variables and as the data came from multiple centers, the results have strong external validity. Our findings suggest that subarachnoid extension in ICH is often restricted to a few sulci of the ipsilateral convexity. Given the strong association between the amount of subarachnoid hemorrhage and the risk of delayed cerebral ischemia in patients with ruptured intracranial aneurysms, 7, 8 it is unlikely that the small amounts of sulcal hemorrhage often observed in ICH would be a major determinant of outcome. Although a generalized pattern of subarachnoid extension was associated with greater mortality in univariable analysis, this association was no longer significant after adjustment for other covariates.
Our study is limited in being subsidiary to the overall design of the trial and for the number of patients with each type of subarachnoid extension being insufficient to allow detailed multivariable analyses.
In summary, subarachnoid extension is associated with more severe clinical grade at presentation and poorer 90-day prognosis in acute ICH. The prognostic significance of subarachnoid extension of ICH on clinical outcome can be explained by its association with larger hematoma volumes.
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Supplemental Methods
CT substudy
In a predefined CT substudy of the INTERACT2 trial, 964 selected patients underwent a repeat CT at 24 hours using the same procedure as the baseline CT with digital images analyzed centrally. Delayed subarachnoid extension of intracerebral hemorrhage (ICH) was defined as new-onset subarachnoid extension on the repeat CT scan alone.
Statistical analysis
The effects of subarachnoid extension on death/major disability, death and major disability were ascertained by logistic regression models. Association of subarachnoid extension on the modified Rankin Scale (mRS) score was also calculated using an ordinal logistic regression model. In multivariable analyses, age, region, lipid lowering therapy, systolic BP, glucose, location of hematoma, intraventricular extension, and randomized treatment at baseline were included into the model 1, while baseline hematoma volume was also included into the model 2. As a sensitivity analysis, additional adjustment for seizures during follow-up was conducted (model 3: variables in model 1 + seizures; model 4: variables in model 2 + seizures). Baseline scores on the Glasgow Coma Scale (GCS) and National Institute of Health Stroke Scale (NIHSS) were not included in the models to avoid over-adjustment. The data were reported with 95% confidence intervals (CI). Analyses were performed using SAS statistical software (version 9.3). BP indicates blood pressure; GCS, Glasgow Coma Scale; NIHSS, National Institutes of Health Stroke Scale; mRS, the modified Rankin Scale; CT, Computed tomography. *GCS scores can range from 3 (deep coma) to 15 (normal, alert).
Supplemental
† NIHSS scores can range from 0 (normal, no neurological deficit) to 42 (coma with quadriplegia). 
